Cite
HARVARD Citation
Lee, S. et al. (n.d.). Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first‐line therapy: A Korean multicenter study. Journal of gastroenterology and hepatology. 29 (7), pp. 1463-1469. [Online].